{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:20:24Z","timestamp":1790400024750,"version":"4.1.0"},"reference-count":37,"publisher":"Society of Nuclear Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.2967\/jnumed.118.221416","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T19:33:43Z","timestamp":1544816023000},"page":"924-929","source":"Crossref","is-referenced-by-count":14,"title":["<i>N<\/i>-(2-(Dimethylamino)Ethyl)-4-<sup>18<\/sup>F-Fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma"],"prefix":"10.2967","volume":"60","author":[{"given":"Ayoung","family":"Pyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misun","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Joon","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2018,12,14]]},"reference":[{"key":"2021051712133027000_60.7.924.1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejca.2016.05.005","article-title":"Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline\u2014update 2016","volume":"63","author":"Garbe","year":"2016","journal-title":"Eur J Cancer."},{"key":"2021051712133027000_60.7.924.2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejca.2016.01.011","article-title":"Treatment patterns of advanced malignant melanoma (stage III-IV): a review of current standards in Europe","volume":"60","author":"Harries","year":"2016","journal-title":"Eur J Cancer."},{"key":"2021051712133027000_60.7.924.3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2174\/1381612824666180125093357","article-title":"The emerging therapeutic landscape of advanced melanoma","volume":"24","author":"Henriques","year":"2018","journal-title":"Curr Pharm Des."},{"key":"2021051712133027000_60.7.924.4","doi-asserted-by":"publisher","DOI":"10.1021\/jm301740k"},{"key":"2021051712133027000_60.7.924.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.104208"},{"key":"2021051712133027000_60.7.924.6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0708436104"},{"key":"2021051712133027000_60.7.924.7","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1346-8138.2010.00880.x","article-title":"Malignant melanoma of the breast: N-isopropyl-p-123I-iodoamphetamine single photon emission computed tomography (123I-IMP SPECT) is useful for the detection of metastasis","volume":"37","author":"Ito","year":"2010","journal-title":"J Dermatol."},{"key":"2021051712133027000_60.7.924.8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s10384-010-0915-9","article-title":"Diagnosis of uveal malignant melanoma by a new semiquantitative assessment of N-isopropyl-p-[123I]-iodoamphetamine","volume":"55","author":"Yoshimura","year":"2011","journal-title":"Jpn J Ophthalmol."},{"key":"2021051712133027000_60.7.924.9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10384-003-0016-0","article-title":"The clinical role of N-isopropyl-p-[123I]-iodoamphetamine single photon emission computed tomography in the follow-up of choroidal melanoma after radiotherapy","volume":"48","author":"Sou","year":"2004","journal-title":"Jpn J Ophthalmol."},{"key":"2021051712133027000_60.7.924.10","first-page":"315","article-title":"The relationship of the eye uptake of N-isopropyl-p-[123I]iodoamphetamine to melanin production","volume":"25","author":"Holman","year":"1984","journal-title":"J Nucl Med."},{"key":"2021051712133027000_60.7.924.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.066175"},{"key":"2021051712133027000_60.7.924.12","first-page":"1573","article-title":"Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma","volume":"32","author":"Michelot","year":"1991","journal-title":"J Nucl Med."},{"key":"2021051712133027000_60.7.924.13","first-page":"1741","article-title":"Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM)","volume":"35","author":"Maffioli","year":"1994","journal-title":"J Nucl Med."},{"key":"2021051712133027000_60.7.924.14","first-page":"1260","article-title":"Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide)","volume":"34","author":"Michelot","year":"1993","journal-title":"J Nucl Med."},{"key":"2021051712133027000_60.7.924.15","first-page":"127","article-title":"Pharmacokinetics of iodine-123-IMBA for melanoma imaging","volume":"38","author":"Nicholl","year":"1997","journal-title":"J Nucl Med."},{"key":"2021051712133027000_60.7.924.16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1099-1344(199906)42:6<567::AID-JLCR217>3.0.CO;2-P","article-title":"Technetium-99m radiolabelling of an N-amino-alkyl-benzamide nitrido- and oxo-technetium bis(aminoethanethiol) derivative synthesis and biological results: potential melanoma tracer agents","volume":"42","author":"Auzeloux","year":"1999","journal-title":"J Labelled Comp Radiopharm."},{"key":"2021051712133027000_60.7.924.17","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1344(199904)42:4<325::AID-JLCR193>3.3.CO;2-A"},{"key":"2021051712133027000_60.7.924.18","doi-asserted-by":"publisher","DOI":"10.1021\/jm981089a"},{"key":"2021051712133027000_60.7.924.19","doi-asserted-by":"publisher","DOI":"10.1021\/jm0010825"},{"key":"2021051712133027000_60.7.924.20","doi-asserted-by":"crossref","first-page":"774","DOI":"10.7150\/jca.17550","article-title":"In vivo imaging of experimental melanoma tumors using the novel radiotracer 68Ga-NODAGA-procainamide (PCA)","volume":"8","author":"Kert\u00e9sz","year":"2017","journal-title":"J Cancer."},{"key":"2021051712133027000_60.7.924.21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jpba.2017.02.049","article-title":"Comparative preclinical evaluation of 68Ga-NODAGA and 68Ga-HBED-CC conjugated procainamide in melanoma imaging","volume":"139","author":"Trencs\u00e9nyi","year":"2017","journal-title":"J Pharm Biomed Anal."},{"key":"2021051712133027000_60.7.924.22","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1016\/j.bmcl.2016.06.022","article-title":"Preparation and characterization of a novel Al18F-NOTA-BZA conjugate for melanin-targeted imaging of malignant melanoma","volume":"26","author":"Chang","year":"2016","journal-title":"Bioorg Med Chem Lett."},{"key":"2021051712133027000_60.7.924.23","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1016\/j.bmc.2012.06.047","article-title":"Synthesis and characterization of a 68Ga-labeled N-(2-diethylaminoethyl)benzamide derivative as potential PET probe for malignant melanoma","volume":"20","author":"Kim","year":"2012","journal-title":"Bioorg Med Chem."},{"key":"2021051712133027000_60.7.924.24","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1016\/j.bmcl.2012.06.043","article-title":"Synthesis and evaluation of a novel 68Ga-labeled DOTA-benzamide derivative for malignant melanoma imaging","volume":"22","author":"Kim","year":"2012","journal-title":"Bioorg Med Chem Lett."},{"key":"2021051712133027000_60.7.924.25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/bc8005094","article-title":"Design, synthesis, and preliminary in vitro and in vivo evaluation of N-(2-diethylaminoethyl)-4-[18F]fluorobenzamide ([18F]-DAFBA): a novel potential PET probe to image melanoma tumors","volume":"20","author":"Garg","year":"2009","journal-title":"Bioconjug Chem."},{"key":"2021051712133027000_60.7.924.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.209643"},{"key":"2021051712133027000_60.7.924.27","doi-asserted-by":"publisher","DOI":"10.1002\/jlcr.1758"},{"key":"2021051712133027000_60.7.924.28","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.7150\/thno.18096","article-title":"A high-affinity repebody for molecular imaging of EGFR-expressing malignant tumors","volume":"7","author":"Yun","year":"2017","journal-title":"Theranostics."},{"key":"2021051712133027000_60.7.924.29","unstructured":"Guide for the Care and Use of Laboratory Animals. 8th ed. Washington, DC: National Academy Press; 2011."},{"key":"2021051712133027000_60.7.924.30","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.136275"},{"key":"2021051712133027000_60.7.924.31","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.122499"},{"key":"2021051712133027000_60.7.924.32","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.070060"},{"key":"2021051712133027000_60.7.924.33","doi-asserted-by":"crossref","first-page":"912498","DOI":"10.1155\/2014\/912498","article-title":"Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma","volume":"2014","author":"Wu","year":"2014","journal-title":"BioMed Res Int."},{"key":"2021051712133027000_60.7.924.34","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1021\/mp400225s","article-title":"A novel aliphatic 18F-labeled probe for PET imaging of melanoma","volume":"10","author":"Liu","year":"2013","journal-title":"Mol Pharm."},{"key":"2021051712133027000_60.7.924.35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/cancers3010126","article-title":"Decoding melanoma metastasis","volume":"3","author":"Damsky","year":"2010","journal-title":"Cancers (Basel)."},{"key":"2021051712133027000_60.7.924.36","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24852"},{"key":"2021051712133027000_60.7.924.37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39519.646424.BE"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.118.221416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:40:05Z","timestamp":1621284005000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.118.221416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,14]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,1]]},"published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.2967\/jnumed.118.221416"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.118.221416","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,14]]}}}